Biggest thing I see is its ability to get taken up not only by the turmour mass but the CTC's is especially welcome news. If this can help chase down CTC cells that's a huge advantage and a literal life saver. So many survive the initial tumour only to have it pop up somewhere else. The two wavelength activation is impressive also. Giving doctors visibility of what and where will be very beneficial in many ways.
Ann: Animal studies show IVX-P02 potential in metastatic cancers, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.336M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 11.0¢ | 10.0¢ | $13.77K | 134.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 186205 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 105955 | 3 |
View Market Depth
| Last trade - 15.54pm 27/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |